Stock listing

Aquis:LONNZ Lonza Group AG Share Price

UK listing (Aquis) of Lonza Group AG · home listing SIX Swiss:LONN

Follow Lonza Group AG into a list and get an email when it puts out news.

Home listing price · SIX:LONN

625.00 CHF +11.80 (+1.9%)

Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SIX:LONN

Past 3 months +7.7% · daily closes, Jul 6, 2026 – Oct 20, 2026, adjusted for splits

Day range: 609.60 – 626.80 CHFOct 20, 2026
Volume: 192,594 sharesOct 20, 2026
Market cap: 43.65B CHFAt the close on Oct 20, 2026 · price × 69.84M shares outstanding

Prices by listing

Listing	Last	Change	Volume	Open	High	Low	Previous close	Price from
SIX Swiss:LONN · Home	625.00 CHF	+11.80 (+1.9%)	192,594	615.00	626.80	609.60	613.20	Close on Oct 20, 2026
LSE:0QNO	621.19 CHF	+9.391 (+1.5%)	17,803	615.00	626.40	610.40	611.80	Close on Oct 20, 2026
OTC:LZAGY	$74.06 USD	+1.32 (+1.8%)	1,996	$73.69	$74.40	$73.57	$72.74	Close on Oct 19, 2026
OTC:LZAGF	$745.00 USD	+15.40 (+2.1%)	12	$745.00	$745.00	$745.00	$729.60	Close on Oct 19, 2026
Frankfurt:LO3A	€65.00 EUR	+0.50 (+0.8%)	—	€65.00	€65.00	€65.00	€64.50	Close on Oct 20, 2026
Munich:LO3	€658.40 EUR	+10.40 (+1.6%)	—	€657.20	€658.40	€657.20	€648.00	Close on Oct 20, 2026
Dusseldorf:LO3	€673.00 EUR	+16.60 (+2.5%)	—	€655.60	€673.00	€655.60	€656.40	Close on Oct 20, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 20, 2026 · SIX:LONN · CHF, adjusted for splits

Day	Close	Change	%	Open	High	Low	Volume
Tue, Oct 20	625.00	+11.80	+1.9%	615.00	626.80	609.60	192,594
Mon, Oct 19	613.20	+9.20	+1.5%	598.80	613.20	598.80	155,938
Fri, Oct 16	604.00	+0.20	0.0%	602.40	606.80	597.60	170,304
Thu, Oct 15	603.80	+18.40	+3.1%	593.40	608.40	588.40	225,545
Wed, Oct 14	585.40	+19.00	+3.4%	565.60	588.40	564.00	224,750
Tue, Oct 13	566.40	-7.60	-1.3%	572.20	578.00	566.00	117,038
Mon, Oct 12	574.00	+1.80	+0.3%	574.20	577.00	570.60	57,521
Fri, Oct 9	572.20	+8.80	+1.6%	570.00	575.80	568.40	77,924
Thu, Oct 8	563.40	-13.80	-2.4%	570.60	570.80	563.40	130,501
Wed, Oct 7	577.20	+1.00	+0.2%	573.80	580.20	570.80	93,866
Tue, Oct 6	576.20	+1.40	+0.2%	579.20	591.80	574.60	140,603
Mon, Oct 5	574.80	+9.20	+1.6%	565.00	578.40	560.40	108,584
Fri, Oct 2	565.60	+5.00	+0.9%	557.00	570.20	554.40	94,395
Thu, Oct 1	560.60	-14.60	-2.5%	569.60	574.40	560.20	103,170
Wed, Sep 30	575.20	-8.80	-1.5%	588.00	591.60	574.60	133,383
Tue, Sep 29	584.00	-0.20	0.0%	584.00	587.40	579.00	116,194
Mon, Sep 28	584.20	+15.00	+2.6%	573.60	584.20	573.60	91,463
Fri, Sep 25	569.20	-0.80	-0.1%	571.00	573.00	562.20	74,785
Thu, Sep 24	570.00	+8.20	+1.5%	559.20	573.80	559.20	131,558
Wed, Sep 23	561.80	-1.00	-0.2%	561.40	565.00	559.00	101,799
Tue, Sep 22	562.80	+14.00	+2.6%	550.20	563.80	549.60	101,345
Mon, Sep 21	548.80	+3.20	+0.6%	548.20	552.20	547.60	75,753
Fri, Sep 18	545.60	+0.60	+0.1%	543.80	551.40	543.80	268,844
Thu, Sep 17	545.00	+6.60	+1.2%	541.00	547.00	537.80	156,031
Wed, Sep 16	538.40	+1.20	+0.2%	536.40	541.60	534.80	180,307
Tue, Sep 15	537.20	+3.00	+0.6%	531.40	537.80	527.00	144,767
Mon, Sep 14	534.20	+3.00	+0.6%	533.00	541.00	532.40	129,404
Fri, Sep 11	531.20	-3.80	-0.7%	535.00	540.40	530.20	131,927
Thu, Sep 10	535.00	-3.00	-0.6%	537.20	543.80	535.00	156,210
Wed, Sep 9	538.00	-18.00	-3.2%	552.40	553.60	533.60	220,828
Tue, Sep 8	556.00	-4.60	-0.8%	560.40	565.00	553.60	165,475
Mon, Sep 7	560.60	-6.60	-1.2%	564.00	564.00	556.20	101,619
Fri, Sep 4	567.20	-14.80	-2.5%	583.00	583.40	567.20	96,094
Thu, Sep 3	582.00	-1.40	-0.2%	583.80	589.00	576.60	127,379
Wed, Sep 2	583.40	+5.60	+1.0%	578.00	591.60	576.00	107,310
Tue, Sep 1	577.80	+1.20	+0.2%	576.00	580.00	572.00	99,501
Mon, Aug 31	576.60	-7.20	-1.2%	580.00	583.00	576.00	193,007
Fri, Aug 28	583.80	-4.60	-0.8%	589.40	590.40	583.00	75,798
Thu, Aug 27	588.40	+0.60	+0.1%	587.60	588.80	583.60	85,614
Wed, Aug 26	587.80	-6.00	-1.0%	591.60	594.60	586.80	110,205
Tue, Aug 25	593.80	+6.00	+1.0%	592.00	597.80	589.00	87,674
Mon, Aug 24	587.80	-4.40	-0.7%	591.20	593.00	584.80	100,687
Fri, Aug 21	592.20	+6.40	+1.1%	584.80	594.00	581.60	135,304
Thu, Aug 20	585.80	+6.60	+1.1%	582.00	588.20	579.80	123,334
Wed, Aug 19	579.20	+13.40	+2.4%	560.20	581.80	560.20	125,258
Tue, Aug 18	565.80	-0.60	-0.1%	566.00	568.40	563.40	65,307
Mon, Aug 17	566.40	+3.80	+0.7%	562.00	568.40	558.60	91,340
Fri, Aug 14	562.60	-10.20	-1.8%	572.80	574.00	556.60	114,419
Thu, Aug 13	572.80	+6.60	+1.2%	568.80	576.80	568.20	91,987
Wed, Aug 12	566.20	-9.20	-1.6%	573.60	573.60	561.60	123,757
Tue, Aug 11	575.40	-4.20	-0.7%	578.00	580.60	573.40	71,815
Mon, Aug 10	579.60	+7.40	+1.3%	575.00	579.60	572.80	97,503
Fri, Aug 7	572.20	+5.60	+1.0%	566.60	579.60	566.60	110,508
Thu, Aug 6	566.60	+5.20	+0.9%	568.00	569.00	564.00	98,994
Wed, Aug 5	561.40	+5.00	+0.9%	559.80	562.00	552.80	95,131
Tue, Aug 4	556.40	-3.80	-0.7%	562.00	566.60	556.40	126,978
Mon, Aug 3	560.20	-2.00	-0.4%	565.80	569.60	560.20	136,879
Fri, Jul 31	562.20	-8.00	-1.4%	575.60	576.20	562.20	154,142
Thu, Jul 30	570.20	-4.60	-0.8%	572.80	580.20	568.80	153,188
Wed, Jul 29	574.80	+14.60	+2.6%	560.00	574.80	558.40	190,174
Tue, Jul 28	560.20	+0.80	+0.1%	561.40	568.00	554.80	116,538
Mon, Jul 27	559.40	+11.40	+2.1%	554.00	559.40	547.80	183,605
Fri, Jul 24	548.00	+5.80	+1.1%	545.00	551.00	544.00	114,522
Thu, Jul 23	542.20	+5.80	+1.1%	540.00	548.60	533.40	171,929
Wed, Jul 22	536.40	-27.60	-4.9%	550.40	553.80	527.40	291,356
Tue, Jul 21	564.00	-1.00	-0.2%	558.00	569.80	554.00	248,872
Mon, Jul 20	565.00	-2.80	-0.5%	565.00	569.40	560.00	150,471

Ticker: Aquis:LONNZ
Asset type: Stock
Sector: Health care
Industry: Diagnostics & research services
Exchange: Aquis
Currency: CHF

What changed lately

Latest news release · Oct 14, 2026
Lonza Upgrades Organic Growth Model and Mid-term Financial Ambitions at Capital Markets Day; Q3 2026 In Line with Expectations
Latest earnings call · Jul 22, 2026
Lonza Group (SIX Swiss: LONN) Q2 2026 Earnings Call
Replay and transcript
Watch replay
Latest deck · Jul 22, 2026
H1 2026 Earnings Presentation
Earnings · 33 slides

Calls

Replays

Lonza Group (SIX Swiss: LONN) Q2 2026 Earnings Call
Wed, Jul 22, 2026 · 8:00 AM ET
Watch Transcript
Lonza Group (SIX Swiss: LONN) Q1 2026 Earnings Call
Fri, May 08, 2026 · 8:00 AM ET
Watch Transcript
Lonza Group (SIX Swiss: LONN) Q4 2025 Earnings Call
Wed, Jan 28, 2026 · 8:00 AM ET
Watch Transcript

Latest news

Lonza Upgrades Organic Growth Model and Mid-term Financial Ambitions at Capital Markets Day; Q3 2026 In Line with Expectations

Oct 14, 2026

Closed 585.40 (+3.4%) on Oct 14, 2026

Lonza Expands Dual-Payload ADC Technology Offering Through Exclusive Access to Qurient’s CDK7 Inhibitors

Oct 12, 2026

Closed 574.00 (+0.3%) on Oct 12, 2026

Lonza Nominates Pearl Huang as Independent Board Member

Sep 30, 2026

Closed 575.20 (-1.5%) on Sep 30, 2026

Lonza Group: Further Strengthens US Manufacturing Presence with Addition of a Commercial Spray-Drying Facility in Bend, Oregon

Sep 10, 2026

Closed 535.00 (-0.6%) on Sep 10, 2026

Lonza Appoints Samanta Cimitan as Chief Commercial Officer

Aug 26, 2026

Closed 588.40 (+0.1%) on Aug 27, 2026

Leading the Future of Oral Delivery, Lonza Capsugel brings breakthrough Capsule Technologies to the Korean Market at CPHI Korea

Aug 5, 2026

Closed 561.40 (+0.9%) on Aug 5, 2026

Lonza Delivered Strong H1 2026 Performance Across All Business Platforms and Upgrades Full-Year 2026 Margin Outlook

Jul 22, 2026

Closed 536.40 (-4.9%) on Jul 22, 2026

Lonza Expands Strategic Collaboration with Leading US Biopharmaceutical Company

Jul 1, 2026

Lonza Expands HPAPI Capacity in Visp, Further Supporting its Position in Payload-Linker Manufacturing

Jun 30, 2026

Lonza Publishes Restated Half-Year 2025 Financials Reflecting Capsules & Health Ingredients as Discontinued Operations

Jun 23, 2026

All Lonza Group AG news

Decks

H1 2026 Earnings Presentation
Earnings · 33 slides · Jul 22, 2026
FY2025 Earnings Presentation
Earnings · 44 slides · Jan 28, 2026
H1 2025 Earnings Presentation
Earnings · 33 slides · Jul 23, 2025
H1 2024 Earnings Presentation
Earnings · 33 slides · Jul 25, 2024

Lonza Group AG on 6ix

Sector: Health care
Industry: Diagnostics & research services
News releases: 24 in the last 12 months · 33 in all · newest Oct 14, 2026 · oldest 2025
Calls: 11 calls with a replay · 11 with a transcript · latest Jul 22, 2026
Decks: 7 decks · latest Jul 22, 2026

Where Lonza Group AG is listed

Listing	Exchange	Country	Currency
SIX Swiss:LONN · Home listing	SIX Swiss	Switzerland	CHF
LSE:0QNO	LSE	United Kingdom	CHF
OTC:LZAGY	OTC	United States	USD
gettex:LO3	gettex	Germany	EUR
Milan:1LONN	Milan	Italy	EUR
OTC:LZAGF	OTC	United States	USD
Aquis:LONNZ · This page	Aquis	United Kingdom	CHF
Tradegate:LO3	Tradegate	Germany	EUR
SGX:O6Z	SGX	Singapore	SGD
Cboe Canada:LON	Cboe Canada	Canada	CAD
LS Exchange:928619	LS Exchange	Germany	EUR
BX Swiss:LO3	BX Swiss	Switzerland	CHF
Lang & Schwarz:928619	Lang & Schwarz	Germany	EUR
VIE:LONN	Vienna	Austria	EUR
Frankfurt:LO3	Frankfurt	Germany	EUR
LS Exchange:A0YF75	LS Exchange	Germany	EUR
Stuttgart:LO3A	Stuttgart	Germany	EUR
Frankfurt:LO3A	Frankfurt	Germany	EUR
Lang & Schwarz:A0YF75	Lang & Schwarz	Germany	EUR
Munich:LO3	Munich	Germany	EUR
Stuttgart:LO3	Stuttgart	Germany	EUR
Turquoise:LONNZ	Turquoise	United Kingdom	CHF
BIVA:LONNN	BIVA	Mexico	MXN
BMV:LONNN	BMV	Mexico	MXN
Dusseldorf:LO3	Dusseldorf	Germany	EUR
Dusseldorf:LO3A	Dusseldorf	Germany	EUR
Frankfurt:LO31	Frankfurt	Germany	EUR
gettex:LO3A	gettex	Germany	EUR
Hamburg:LO3	Hamburg	Germany	EUR

Aquis:LONNZ Lonza Group AG Share Price

Prices by listing

Daily closes

What changed lately

Lonza Upgrades Organic Growth Model and Mid-term Financial Ambitions at Capital Markets Day; Q3 2026 In Line with Expectations

Lonza Group (SIX Swiss: LONN) Q2 2026 Earnings Call

H1 2026 Earnings Presentation

Calls

Replays

Latest news

Lonza Upgrades Organic Growth Model and Mid-term Financial Ambitions at Capital Markets Day; Q3 2026 In Line with Expectations

Lonza Expands Dual-Payload ADC Technology Offering Through Exclusive Access to Qurient’s CDK7 Inhibitors

Lonza Nominates Pearl Huang as Independent Board Member

Lonza Group: Further Strengthens US Manufacturing Presence with Addition of a Commercial Spray-Drying Facility in Bend, Oregon

Lonza Appoints Samanta Cimitan as Chief Commercial Officer

Leading the Future of Oral Delivery, Lonza Capsugel brings breakthrough Capsule Technologies to the Korean Market at CPHI Korea

Lonza Delivered Strong H1 2026 Performance Across All Business Platforms and Upgrades Full-Year 2026 Margin Outlook

Lonza Expands Strategic Collaboration with Leading US Biopharmaceutical Company

Lonza Expands HPAPI Capacity in Visp, Further Supporting its Position in Payload-Linker Manufacturing

Lonza Publishes Restated Half-Year 2025 Financials Reflecting Capsules & Health Ingredients as Discontinued Operations

Decks

H1 2026 Earnings Presentation

FY2025 Earnings Presentation

H1 2025 Earnings Presentation

H1 2024 Earnings Presentation

Lonza Group AG on 6ix

Where Lonza Group AG is listed